Stoquity Living researchResearch LedgerSlicesMethodologyFor institutionsAbout
Stoquity Research Ledger

Steris (STE)

NYSE: STE · Health Care Equipment · Dublin, L2

Our rating: Neutral

Call changed from Positive to Neutral at $252.30, moderate conviction, November 6, 2026.

Breaks if: The Neutral call turns Cautious if revenue growth decelerates below 5% for two consecutive quarters — it is running at 8.7% now, so that would signal genuine franchise momentum loss — or if net margin falls below 11%, which at this multiple would be difficult to defend without sharp multiple compression. It turns Positive if free cash flow yield rises durably above 4.5% through margin expansion rather than a price pullback alone, or if revenue growth re-accelerates above 10% for two straight quarters, suggesting the business is running meaningfully ahead of current market expectations.

Key figures

Market value$24.8B
Revenue, last 12 months$6.2B
Net income, last 12 months$827M
Free cash flow, last 12 months$937M
Price to earnings30.0×
Free cash flow yield3.8%
Dividend yield1.0%
Operating margin19.0%
Return on equity11.6%
Beta to the S&P 5000.44
Volatility, annualized24.1%

Reported quarters

Quarter endingRevenueYear on yearEarnings per shareFree cash flow
September 30, 2026$1.6B8.8%n/a$213M
June 30, 2026$1.5B7.3%n/a$280M
March 31, 2026$1.6B7.3%$2.24$245M
December 31, 2025$1.5B9.2%$1.96$200M
September 30, 2025$1.5B9.9%$1.94$201M
June 30, 2025$1.4B8.7%$1.79$326M
March 31, 2025$1.5B4.3%$1.47$190M
December 31, 2024$1.4B5.6%$1.75$244M

Three-model forecasts for the next quarter

Written November 21, 2026, before the report. Each settles from the SEC filing.

6 ledger entries and 27 corporate events on record. Share price as of November 20, 2026. Research and education only. Not investment advice. Stoquity does not manage money or know your circumstances. Ratings, forecasts and lists are produced by software and AI models and can be wrong. Performance figures are hypothetical, measured on paper against a benchmark, and say nothing certain about the future.